Macrocyclics Inc., a subsidiary of Orano Med, specializes in the production of chelating agents used in nuclear medicine. Its main activities include:
● Process chemistry and ligand design.
● Feasibility studies for process optimization.
● Bioconjugation development and cGMP manufacturing.
● Custom design, manufacture, and cGMP production of chelates.
● Identification and selection of appropriate chelating agents for specific applications.